warfarin

Atherosclerosis in Atrial Fibrillation (ATHERO-AF)

Atherosclerosis in Atrial Fibrillation (ATHERO-AF)

Il progetto ATHERO-AF include pazienti affetti da fibrillazione atriale in terapia anticoagulante orale che vengono monitorizzati circa la qualità della terapia e l'insorgenza di eventuali complicanze. In aggiunta al rischio tromboembolico legato alla fibrillazione, lo studio ATHERO-AF ha lo scopo di analizzare fattori legati al rischio cardiovascolare residuo, con particolare attenzione a fattori legati all'aterosclerosi sistemica (tra cui stress ossidativo, attivazione piastrinica, fattori metabolici)

The relationships between vitamin K and cognition: a review of current evidence

Vitamin K is a fat-soluble nutrient discovered in 1935 and its role in blood coagulation has been thoroughly explored. In recent years, studies conducted in vitro and on animals highlighted vitamin K involvement in brain cells development and survival. In particular, vitamin K seems to have an antiapoptotic and anti-inflammatory effect mediated by the activation of Growth Arrest Specific Gene 6 and Protein S. Moreover, this vitamin is involved in sphingolipids metabolism, a class of lipids that participate in the proliferation, differentiation, and survival of brain cells.

Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study

Objectives. Recent studies have suggested that vitamin K may exert significant effects on the central nervous system. The present study investigates the relationship between vitamin K plasmatic levels and cognitive functions in elderly patients on oral anticoagulant therapy (OAT). Design. At the Thrombosis Centre of Haematology, "Sapienza" University of Rome, 85 patients on OAT, aged between 75 and 92, were randomly enrolled in the study. Patients were on OAT with vitamin K antagonists (VKAs).

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma